Top Markets
Coin of the day
Curatis Holding AG Curatis Holding AG

Curatis Holding AG

CURN
株式のランク #20206
Curatis Holding AG specializes in the entire lifecycle of pharmaceutical... Curatis Holding AG specializes in the entire lifecycle of pharmaceutical products, including the procurement, advancement, and market release of medications specifically designed for the diagnosis, prevention, and management of rare and specialized medical conditions. The company's extensive product offerings span a broad array of therapeutic areas. These encompass treatments for antiplatelet conditions, metastatic hormone receptor-positive breast cancer, anti-arrhythmic disorders, nasal oil applications, Wilson's disease, antidotes for cyanide poisoning and digoxin toxicity, antihypotensive agents, therapies for bladder pain syndrome/interstitial cystitis, antibiotics, diagnostic tools for ophthalmology, antivirals, ophthalmic/antibiotic combinations, gentamycin collagen sponges, solutions for benign prostatic hyperplasia, immunomodulators, treatments for epilepsy and essential tremor, thyreostatics, therapies for hereditary tyrosinemia type 1, gastroenterological products, additional immunomodulators and thyreostatics, tranquilizers, Helicobacter pylori tests, phosphate binders, specialized nutritional support for dialysis patients, dermatological corticosteroids, antidotes for lead and mercury poisoning, corticostimulants, anti-fog agents, treatments for chorea associated with Huntington's disease, and antiepileptics. In addition to its commercialized portfolio, Curatis is actively engaged in developing new pharmaceutical compounds. Its pipeline includes C-PTBE-01, currently in Phase IIb clinical trials for treating peritumoral brain edema in pediatric patients; C-AM-01, undergoing Phase IIa trials for preventing severe migraine with aura; and C-MOH-01, also in Phase IIa for the treatment and prevention of medication overuse headache. Furthermore, KIN001 is in Phase I clinical trials, targeting rare inflammatory and fibrotic diseases. The company maintains its headquarters in Liestal, Switzerland.
株価
$25.88
時価総額
$137.20M
変化(1日)
2.05%
変化(1年)
87.77%
CH
取引 Curatis Holding AG (CURN)

カテゴリー

Curatis Holding AG(CURN)の株価履歴
終値の最高値: $25.29 (2026-08-01)

終値の最安値: $1.26M (1999-04-01)
Curatis Holding AG の株価履歴(1999 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 54.44%
2025 2.02%
2024 524.76%
2023 -95.88%
2022 -83.81%
2021 -17.34%
2020 481.84%
2019 37.23%
2018 -52.65%
2017 -17.39%
2016 -30.62%
2015 -47.06%
2014 -44.60%
2013 13.03%
2012 8.19%
2011 -47.25%
2010 -0.13%
2009 146.64%
2008 -94.83%
2007 -25.49%
2006 -36.45%
2005 -14.30%
2004 -19.20%
2003 8.14%
2002 88.71%
2001 -91.53%
2000 -89.36%
1999 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$171.67 -
DE
$164.46 25.10%
DE
$37.82 21.13%
JP
$222.79 32.01%
CH
$21.08 12.12%
IN